DNTH vs MKTX · rev $6.2M vs P/E 13, rev $817.1M
Dianthus Therapeutics Inc. (DNTH) versus MarketAxess Holdings Inc (MKTX) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported MKTX revenue for 2024-12-31 was $817.1M. Net income was $274.2M. Revenue was up 8.6% from 2023-12-31 to 2024-12-31. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
DNTH currently screens at market cap $4.40B. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Not investment advice. Open the DNTH and MKTX stock pages for the full models.
Not investment advice.